Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Cellular Biomedicine secures $43.1M from Dangdai

    Cell therapy company Cellular Biomedicine Group Inc. (NASDAQ:CBMG) is raising $43.1 million through the sale of 2.3 million shares at $19 to Wuhan Dangdai Science and Technology Industries Group. The purchase price is a…

    Published on 2/5/2016
  • FINANCIAL NEWS: Imperial Innovations looks to raise L100M

    Imperial Innovations Group plc (LSE:IVO) plans to raise L100 million ($142.9 million) through a placing of 23.5 million shares at 425p to existing and new institutional investors. The price is a 6% premium to the firm's…

    Published on 2/4/2016
  • FINANCIAL NEWS: KemPharm raises $75M

    Prodrug developer KemPharm Inc. (NASDAQ:KMPH) raised $75 million through the sale of senior unsecured notes in a deal led by Deerfield Management. Book-running managers were Cowen and RBC Capital Markets, and co-…

    Published on 2/4/2016
  • FINANCIAL NEWS: Alexion reports on Strensiq, Kanuma launches

    Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) gained $8.61 to $145.97 Wednesday after reporting 4Q15 and full-year earnings, including early sales of Strensiq asfotase alfa and Kanuma sebelipase alfa.The company reported $…

    Published on 2/3/2016
  • FINANCIAL NEWS: Anti-aging company Unity makes debut

    Unity Biotechnology (San Francisco, Calif.) made its debut on Wednesday with an investment of undisclosed size from Arch Venture Partners, Venrock, WuXi, Mayo Clinic, Unity's management team and undisclosed investors. …

    Published on 2/3/2016
  • FINANCIAL NEWS: Enyo secures EUR 22M to treat viral infections

    Enyo Pharma S.A.S. (Paris, France) raised EUR 6 million ($6.5 million) in the first tranche of a planned EUR 22 million ($23.9 million) series A round led by its seed investor, Sofinnova Partners. Morningside and …

    Published on 2/3/2016
  • FINANCIAL NEWS: LAM closes $40M financing

    LAM Therapeutics (Guilford, Conn.) said it raised $40 million in a venture round from undisclosed investors. The company develops therapeutics for cancer and rare diseases. President and CSO Henri Lichenstein told …

    Published on 2/3/2016
  • FINANCIAL NEWS: Pierre Fabre launches early stage research initiative

    Laboratoires Pierre Fabre S.A. (Castres, France) launched the Pierre Fabre Fund for Innovation, a new strategic initiative through which it will support early stage research programs in dermatology and oncology with the…

    Published on 2/3/2016
  • FINANCIAL NEWS: Index spins out Medicxi Ventures

    Medicxi Ventures debuted on Tuesday with a EUR 210 million ($227.9 million) fund that will focus on early stage life science investments in Europe. Medicxi comprises the life sciences team, funds and portfolio companies…

    Published on 2/2/2016
  • FINANCIAL NEWS: Kadmon mum on IPO rumors

    Kadmon Corp. LLC (New York, N.Y.) did not respond to requests for comment on media reports that said the biotech may file for an IPO as early as this week. IPO signals are nothing new to the company, and date back to …

    Published on 2/2/2016
  • FINANCIAL NEWS: Mission Therapeutics raises L60M

    Mission Therapeutics Ltd. (Cambridge, U.K.) secured L60 million ($85.7 million) in a tranched series C round co-led by existing investor Imperial Innovations Group plc (LSE:IVO) and new investor Woodford Investment …

    Published on 2/2/2016
  • FINANCIAL NEWS: Qiming closes Fund V at $648 million

    Qiming Venture Partners closed its Qiming V fund at $648 million. As with past funds, Qiming will invest Fund V in Chinese healthcare, IT, cleantech, internet and consumer companies, with more than 50% of its …

    Published on 2/2/2016
  • FINANCIAL NEWS: Spero closes $30M series B round

    Anti-infective play Spero Therapeutics LLC (Cambridge, Mass.) secured $30 million in a tranched series B round from existing investors Atlas Venture, SR One, MRL Ventures, Lundbeckfond Ventures, the Kraft Group and …

    Published on 2/2/2016
  • FINANCIAL NEWS: Sinovac mulls take-private proposal

    Sinovac Biotech Ltd. (NASDAQ:SVA) gained $0.78 (16%) to $5.80 on Monday after it received a non-binding proposal from President and CEO Weidong Yin and existing shareholder SAIF Partners to acquire all outstanding …

    Published on 2/1/2016
  • FINANCIAL NEWS: AbbVie reports 4Q15 results

    AbbVie Inc. (NYSE:ABBV) reported 4Q15 and 2015 financial results Friday that were in-line with consensus estimates, although its U.S. 4Q sales of HCV regimen Viekira Pak missed expectations. U.S. Viekira sales were $197…

    Published on 1/29/2016
  • FINANCIAL NEWS: Financial tracks

    Frazier Healthcare Partners named Anthony Draye executive partner on its growth buyout team. Draye was director of applications for TridentUSA Health Services (Glencoe, Md.).Tech transfer and investment firm …

    Published on 1/29/2016
  • FINANCIAL NEWS: BMS tops Street, halts Opdivo head/neck trial early

    Bristol-Myers Squibb Co. (NYSE:BMY) reported 4Q15 and 2015 financial results that beat estimates and said a Phase III trial of Opdivo nivolumab to treat squamous cell carcinoma of the head and neck (SCCHN) was stopped …

    Published on 1/28/2016
  • FINANCIAL NEWS: Celgene to adjust 2017 guidance

    Celgene Corp. (NASDAQ:CELG) slid $5.10 to $97.21 on Thursday after reporting 4Q15 earnings and signaling that it will likely revise 2017 guidance.In response to a question on a conference call Thursday, Celgene EVP and …

    Published on 1/28/2016
  • FINANCIAL NEWS: Chinese antibody play Adagene raises $28M

    Adagene Inc. (Suzhou, China) raised $28 million in a series B round led by new investor GP Healthcare Capital. Also participating were new investor New World TMT and existing investors Eight Roads Ventures China (…

    Published on 1/28/2016
  • FINANCIAL NEWS: Adicet raises $51 million series A

    Adicet Bio Inc. (Menlo Park, Calif.) raised $51 million in a series A round led by OrbiMed. Other investors included Novartis Venture Fund and Pontifax. Adicet said it is developing preclinical universal immune cell …

    Published on 1/27/2016
  • FINANCIAL NEWS: Novartis contrasts Entresto, Cosentyx uptake

    Novartis AG (NYSE:NVS; SIX:NOVN) reported 4Q15 and full-year financial results and provided an update on the recent launches of two drugs it expects could become the pharma's biggest assets, heart failure drug Entresto …

    Published on 1/27/2016
  • FINANCIAL NEWS: Tarveda raises $38M series C

    Tarveda Therapeutics Inc. (Watertown, Mass.) raised $38 million in a series C round led by new investor Novo A/S (Hellerup, Denmark) and founding investor New Enterprise Associates. Existing investors Flagship Ventures,…

    Published on 1/27/2016
  • FINANCIAL NEWS: Exosome play Codiak closes $61M B round

    Exosome-based diagnostics and therapeutics play Codiak BioSciences Inc. (Cambridge, Mass.) said it closed a series B round with $61 million. Flagship Ventures and Arch Venture Partners co-led both the new round and …

    Published on 1/26/2016
  • FINANCIAL NEWS: Inivata closes L31.5M round

    Cancer diagnostics play Inivata Ltd. (Cambridge, U.K.) raised L31.5 million ($44.9 million) in a series A round. The company plans to accelerate clinical trials of its enhanced TAm-Seq circulating tumor DNA (ctDNA) …

    Published on 1/26/2016
  • FINANCIAL NEWS: Chinese CAR-T play CARsgen raises $30M

    CARsgen Therapeutics Co. Ltd. (Shanghai, China) raised $30 million in a series B round led by KTB Ventures and Jolly Innovation Ventures. Kaitai Capital and JIC GenesisFountain Healthcare Ventures also participated.…

    Published on 1/25/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993